» Articles » PMID: 25536107

Benchmark Dose Estimation for Cadmium-induced Renal Tubular Damage Among Environmental Cadmium-exposed Women Aged 35-54 Years in Two Counties of China

Overview
Journal PLoS One
Date 2014 Dec 24
PMID 25536107
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A number of factors, including gender, age, smoking habits, and occupational exposure, affect the levels of urinary cadmium. Few studies have considered these influences when calculating the benchmark dose (BMD) of cadmium. In the present study, we aimed to calculate BMDs and their 95% lower confidence bounds (BMDLs) for cadmium-induced renal tubular effects in an age-specific population in south-central China.

Methods: In this study, urinary cadmium, β2-microglobulin, and N-acetyl-β-D-glucosaminidase levels were measured in morning urine samples from 490 randomly selected non-smoking women aged 35-54 years. Participants were selected using stratified cluster sampling in two counties (counties A and B) in China. Multiple regression and logistic regression analyses were used to investigate the dose-response relationship between urinary cadmium levels and tubular effects. BMDs/BMDLs corresponding to an additional risk (benchmark response) of 5% and 10% were calculated with assumed cut-off values of the 84th and 90th percentile of urinary β2-microglobulin and N-acetyl-β-D-glucosaminidase levels of the controls.

Results: Urinary levels of β2-microglobulin and N-acetyl-β-D-glucosaminidase increased significantly with increasing levels of urinary cadmium. Age was not associated with urinary cadmium levels, possibly because of the narrow age range included in this study. Based on urinary β2-microglobulin and N-acetyl-β-D-glucosaminidase, BMDs and BMDLs of urinary cadmium ranged from 2.08 to 3.80 (1.41-2.18) µg/g cr for subjects in county A and from 0.99 to 3.34 (0.74-1.91) µg/g cr for those in county B. The predetermined benchmark response of 0.05 and the 90th percentiles of urinary β2-microglobulin and N-acetyl-β-D-glucosaminidase levels of the subjects not exposed to cadmium (i.e., the control group) served as cut-off values.

Conclusions: The obtained BMDs of urinary cadmium were similar to the reference point of 1 µg/g cr, as suggested by the European Food Safety Authority, indicating that cadmium exposure must be reduced to protect human health.

Citing Articles

Recent advances in the clinical management of intoxication by five heavy metals: Mercury, lead, chromium, cadmium and arsenic.

Balali-Mood M, Eizadi-Mood N, Hassanian-Moghaddam H, Etemad L, Moshiri M, Vahabzadeh M Heliyon. 2025; 11(4):e42696.

PMID: 40040983 PMC: 11876891. DOI: 10.1016/j.heliyon.2025.e42696.


Prenatal Metal Exposures and Associations with Kidney Injury Biomarkers in Children.

Politis M, Yao M, Gennings C, Tamayo-Ortiz M, Valvi D, Kim-Schulze S Toxics. 2022; 10(11).

PMID: 36422900 PMC: 9699100. DOI: 10.3390/toxics10110692.


An assessment of sensitivity biomarkers for urinary cadmium burden.

Li Y, Wang H, Yu J, Yan Q, Hu H, Zhang L BMC Nephrol. 2020; 21(1):385.

PMID: 32891117 PMC: 7487760. DOI: 10.1186/s12882-020-02036-9.


Short-term Changes in Urine Beta 2 Microglobulin Following Recovery of Acute Kidney Injury Resulting From Snake Envenomation.

Jaswanth C, Priyamvada P, Zachariah B, Haridasan S, Parameswaran S, Swaminathan R Kidney Int Rep. 2019; 4(5):667-673.

PMID: 31080921 PMC: 6506712. DOI: 10.1016/j.ekir.2019.01.016.


Urinary Cadmium Threshold to Prevent Kidney Disease Development.

Satarug S, Ruangyuttikarn W, Nishijo M, Ruiz P Toxics. 2018; 6(2).

PMID: 29723981 PMC: 6027056. DOI: 10.3390/toxics6020026.


References
1.
Moriguchi J, Inoue Y, Kamiyama S, Horiguchi M, Murata K, Sakuragi S . N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas. Toxicol Lett. 2009; 190(1):1-8. DOI: 10.1016/j.toxlet.2009.05.009. View

2.
Suwazono Y, Uetani M, Akesson A, Vahter M . Recent applications of benchmark dose method for estimation of reference cadmium exposure for renal effects in man. Toxicol Lett. 2010; 198(1):40-3. DOI: 10.1016/j.toxlet.2010.04.015. View

3.
Olsson I, Bensryd I, Lundh T, Ottosson H, Skerfving S, Oskarsson A . Cadmium in blood and urine--impact of sex, age, dietary intake, iron status, and former smoking--association of renal effects. Environ Health Perspect. 2002; 110(12):1185-90. PMC: 1241104. DOI: 10.1289/ehp.021101185. View

4.
Kobayashi E, Suwazono Y, Uetani M, Inaba T, Oishi M, Kido T . Estimation of benchmark dose as the threshold levels of urinary cadmium, based on excretion of total protein, beta2-microglobulin, and N-acetyl-beta-D-glucosaminidase in cadmium nonpolluted regions in Japan. Environ Res. 2006; 101(3):401-6. DOI: 10.1016/j.envres.2005.12.002. View

5.
Bernard A, Thielemans N, Roels H, Lauwerys R . Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med. 1995; 52(3):177-80. PMC: 1128183. DOI: 10.1136/oem.52.3.177. View